Abstract: This presentation demonstrates GSK’s use of automation to keep the biopharmaceutical discovery funnel wider for longer. I will present how GSK has modernised and embedded lab automation and data workflows to deliver high throughput molecular cloning, expression and purification of antibodies. In the presentation I will describe the platforms and technologies that we have designed and developed. Automating the process from first intent; developing, optimising and validating each process step using the final device and removing the need for any lengthy bridging studies. I will showcase the platforms we have enabled to clone, express and purify panels of antibodies in a high-throughput, automated manner, enabling parallel screening for biological function and developability, accelerating the drug discovery process.